Supply of Levothyroxine Sodium 88 MCG Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract involves the annual supply of 5,029 bottles, each containing 90 tablets of Levothyroxine Sodium 88 MCG, for a period of five years. All products must comply with United States Pharmacopeia standards and include correct labeling as required by regulations. This is a subcontract under the Department of Defense’s Medical Supply Chain FSGB, with the solicitation posted on July 13, 2026, and responses due by August 13, 2026. The NAICS code 325412 indicates the product falls under pharmaceutical manufacturing, and performance is expected to support federal healthcare logistics without specifying a geographic location. The contract is not subject to a named set-aside classification and is accessible through the DIBBS platform for qualified bidders.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN FSGB
Same awarding agency
